SecondLine Treatment of Metastatic Renal Cell Carcinoma

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=wYk-Mi8TBQA

In this segment, panelists describe selecting between a VEGF or mTOR inhibitor as a second-line treatment for patients with metastatic renal cell carcinoma following a frontline VEGF inhibitor. • To view more from this segment, visit http://www.onclive.com/peer-exchange/...

#############################

New on site